ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

DCE Board Approves Concept For 14-19 New Grants, Four New Contracts

November 4, 1988

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

NIH funds four centers to study breast cancer and the environment.

October 17, 2003

Nancy Brinker Resigns As CEO of Komen

August 10, 2012